Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The market for mechanical circulatory support devices has witnessed remarkable growth in recent years, driven by advances in technology and increasing cardiac health challenges worldwide. As heart-related conditions become more prevalent, the demand for innovative solutions to assist heart function is expanding rapidly. This overview explores the market’s current size, the main factors fueling its growth, key players shaping the industry, emerging trends, and the segmentation driving future opportunities.
Mechanical Circulatory Support Devices Market Size and Expected Growth Trajectory
The mechanical circulatory support devices market has shown strong momentum, growing from $3.47 billion in 2025 to an estimated $3.82 billion in 2026, with a compound annual growth rate (CAGR) of 10.1%. This positive trend in the historical period is largely due to the limited availability of advanced devices, the continued use of traditional intra-aortic balloon pumps, the rising incidence of heart failure, an increase in cardiac surgeries, and a shortage of standardized training for device implantation. Looking ahead, the market is anticipated to reach $5.59 billion by 2030, maintaining a CAGR of 10.0%. Technological innovations in both pulsatile and non-pulsatile flow devices, the expansion of minimally invasive cardiac procedures, widespread adoption of left and biventricular assist devices, growth in specialty cardiac hospitals, and increased investment in cardiac research are key contributors to this forecast. Notable trends include the rising use of ventricular assist devices and total artificial hearts, more cardiac surgeries and heart failure treatments, growing deployment of extracorporeal membrane oxygenation (ECMO) systems, and a focus on minimally invasive and percutaneous device use, alongside stricter regulatory compliance and safety standards.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27334&type=smp
Rising Heart Failure Cases Boost Market Demand for Mechanical Circulatory Support Devices
An important driver behind the market’s growth is the increasing prevalence of heart failure, a chronic condition where the heart’s ability to pump blood is compromised. The aging global population, which is more susceptible to cardiovascular diseases and complications, is a major factor behind this rise. Mechanical circulatory support devices play a critical role by assisting the heart in pumping blood, easing its workload, and improving circulation. For instance, in September 2024, the Heart Failure Society of America (HFSA) reported that 6.7 million Americans over the age of 20 currently suffer from heart failure. Projections indicate that this figure will increase to 8.7 million by 2030, 10.3 million by 2040, and reach 11.4 million by 2050. This growing patient population is driving demand for advanced circulatory support devices.
Technological Breakthroughs and Increased Adoption Accelerate Growth Prospects
Advancements in device technology, particularly the development of magnetically levitated rotor (MAGLEV) technology, are significantly enhancing mechanical circulatory support devices. MAGLEV technology minimizes friction by suspending rotors magnetically, which extends device lifespan and reliability. For example, in July 2024, BiVACOR Inc., a clinical-stage medical device company in the U.S., successfully performed the first human implantation of its Total Artificial Heart (TAH). Designed to replace both heart ventricles in patients with severe heart failure who are not candidates for conventional devices, this innovation offers a promising bridge to transplant, improving survival rates and quality of life for patients facing limited treatment options due to donor heart shortages.
Access The Complete Mechanical Circulatory Support Devices Market Report:
Mechanical Circulatory Support Devices Market Segmentation Highlights and Growth Opportunities
This market is segmented based on type, technology, application, and end user to better understand its scope and potential:
1) By Type: Intra-Aortic Balloon Pump, Ventricular Assist Device, Total Artificial Heart, Extracorporeal Membrane Oxygenation
2) By Technology: Pulsatile Flow Devices, Non-Pulsatile Flow Devices
3) By Application: Cardiac Surgery, Heart Failure Management, Myocardial Infarction, Cardiogenic Shock
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Users
Subsegments include:
– Intra-Aortic Balloon Pump: Percutaneous and Surgical variants
– Ventricular Assist Device: Left, Right, and Biventricular Assist Devices
– Total Artificial Heart: Pneumatic and Electric types
– Extracorporeal Membrane Oxygenation: Venoarterial and Venovenous systems
This detailed segmentation helps identify targeted growth areas and tailor solutions for specific clinical needs.
Leading Companies Driving Innovation in Mechanical Circulatory Support Devices
The competitive landscape of this market features numerous key players committed to advancing device technology and expanding access to mechanical circulatory support. Prominent companies include Abbott Laboratories, Medtronic Plc, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Jarvik Heart Inc., Carmat SAS, Procyrion Inc., BiVACOR Inc., Evaheart Inc., ReliantHeart Inc., SynCardia Systems LLC, Berlin Heart GmbH, NovaPump GmbH, CardiacAssist Inc., Circulite Medical Inc., Windmill Cardiovascular Systems Inc., NuPulseCV Inc., and FineHeart SAS. These organizations focus heavily on research, innovative product development, and regulatory compliance to meet evolving patient needs.
Regional Market Overview and Growth Forecast
In 2025, North America held the largest market share for mechanical circulatory support devices, reflecting the region’s advanced healthcare infrastructure and high demand. However, the Asia-Pacific region is expected to experience the most rapid growth during the forecast period. The comprehensive market analysis spans multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on emerging trends and investment opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
